Jan 11, 2023 / 04:15PM GMT
Anne Elizabeth Samuel - JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone, and welcome to day 3 of the JPMorgan Healthcare Conference. My name is Annie Samuel, and I'm the health care technology and distribution analyst here at JPMorgan. We're thrilled to have Omnicell with us this morning. CEO and Founder, Randy Lipps, is going to give us a presentation, and then we'll open it up to Q&A afterwards with the whole team. So if you have a question, we'll have a mic runner. We can get your questions answered.
And so with that, let me turn it over to Randy.
Randall A. Lipps - Omnicell, Inc. - Founder, Executive Chairman, President & CEO
I'm going to turn it over to Kathleen for...
Kathleen Nemeth - Omnicell, Inc. - SVP of IR
Yes. Just very briefly -- good morning, everyone. It's great to be here with everyone this morning. Just very briefly, we will be making forward-looking statements during today's presentation. Please be sure to review our SEC filings for a full list of risks
Omnicell Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot